| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 06/23/2011 | US20110150772 Modulators of carnitine octanoyltransferase in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 06/23/2011 | US20110150771 Chimeric west nile/dengue viruses |
| 06/23/2011 | US20110150770 Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine |
| 06/23/2011 | US20110150769 Identification and use of compounds for treating persistent pain |
| 06/23/2011 | US20110150768 Compositions and methods for delivering inhibitory oligonucleotides |
| 06/23/2011 | US20110150767 Alpha-substituted and alpha-unsubstituted aromatic amino acid derivatives and compositions thereof for use to treat, diagnose, or monitor a medical condition |
| 06/23/2011 | US20110150766 Transdermal patch with fatal overdose protection |
| 06/23/2011 | US20110150765 Frozen compositions and methods for piercing a substrate |
| 06/23/2011 | US20110150764 Stroke-tageting peptide and use thereof |
| 06/23/2011 | US20110150761 Polypeptides, polynucleotides encoding same, antibodies thereagainst and methods of using same for diagnosing and treating cancer and skeletal disorders |
| 06/23/2011 | US20110150758 Tracking of bone marrow cells for metastasis screening |
| 06/23/2011 | CA2784327A1 Magnetite in nanoparticulate form |
| 06/23/2011 | CA2781228A1 Manganese chelates and their use as contrast agents in magnetic resonance imaging (mri) |
| 06/22/2011 | EP2335739A1 Molecular probe precursor for imaging of pancreatic islet, and use thereof |
| 06/22/2011 | EP2335575A2 Magnetic gas bubble composition and magnetic gas bubble precursor for its manufacture |
| 06/22/2011 | EP2335574A2 Magnetic gas bubble composition and functionalised magnetic particle composition |
| 06/22/2011 | EP2335573A2 Kit of magnetic particle compositions and functionalised magnetic particle composition |
| 06/22/2011 | EP2334239A1 Isolation of microbubbles of selected size range from polydisperse microbubbles |
| 06/22/2011 | EP1204683B1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 06/22/2011 | DE102009054956A1 Magnetresonanztomographie-Bildgebung Magnetic resonance imaging |
| 06/22/2011 | CN102105175A Nanoparticles, methods of making same and cell labelling using same |
| 06/22/2011 | CN102105174A Diagnostic agents selective against metalloproteases |
| 06/22/2011 | CN102100917A Method for evaluating bioequivalence of plant hollow capsule |
| 06/22/2011 | CN101766826B Preparation method of ferroferric oxide nanoparticles with liver targeting function |
| 06/22/2011 | CN101711882B Medical ultrasound coupling agent with function of fast and efficient sterilization and device thereof |
| 06/22/2011 | CN101670107B Multifunctional nuclear shell structure drug carrier material and preparation method thereof |
| 06/22/2011 | CN101035796B Method of producing a composition, composition and its use |
| 06/21/2011 | US7966056 Magnetic resonance imaging method and compounds for use in the method |
| 06/21/2011 | US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease |
| 06/21/2011 | US7964614 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
| 06/21/2011 | US7964558 Therapeutic applications for C-peptide |
| 06/21/2011 | US7964557 Administering adiponectin; inhibitory effect of adiponectin on choroidal angiogenesis or choroidal neovascularization |
| 06/21/2011 | US7964192 Prevention and treatment of amyloidgenic disease |
| 06/21/2011 | US7964177 Method for determination of oxidative stress |
| 06/21/2011 | CA2320406C Methods of screening agents for activity using teleosts |
| 06/18/2011 | CA2724086A1 Pharmaceutical compounds |
| 06/16/2011 | WO2011071968A2 Nanoparticle carrier systems based on human serum albumin for photodynamic therapy |
| 06/16/2011 | WO2011070358A2 Product and method |
| 06/16/2011 | WO2011069523A1 Composition for labeling and visualizing grafts in magnetic mri and x-ray fluroscopy, and use thereof |
| 06/16/2011 | WO2011069283A1 Method for measuring physiological parameters in cerebral interstitial fluid and cerebral extracellular space |
| 06/16/2011 | WO2011048503A3 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof |
| 06/16/2011 | WO2011017690A3 Intracellular delivery of contrast agents with functionalized nanoparticles |
| 06/16/2011 | US20110144478 Magnetic microstructures for magnetic resonance imaging |
| 06/16/2011 | US20110144477 Method for Acquiring Electromagnetic Signals and Contrast Product Therefor |
| 06/16/2011 | US20110144054 Polyol and Polyether Iron Oxide Complexes as Pharmacological and/or MRI Contrast Agents |
| 06/16/2011 | US20110142862 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 06/16/2011 | US20110142765 Novel phloroglucinol derivatives having selectin ligand activity |
| 06/16/2011 | US20110142764 Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases |
| 06/16/2011 | US20110142763 Megalin-Based Delivery of Therapeutic Compounds to the Brain and Other Tissues |
| 06/16/2011 | US20110142762 Conjugates for medical imaging comprising carrier, targeting moiety and a contrast agent |
| 06/16/2011 | US20110142761 Il-1 binding proteins |
| 06/16/2011 | US20110142757 Novel compounds and their uses in diagnosis |
| 06/16/2011 | CA2784001A1 Nanoparticle carrier systems based on human serum albumin for photodynamic therapy |
| 06/15/2011 | EP2332590A2 Non-degradable low swelling, water soluble radiopaque hydrogels |
| 06/15/2011 | EP2332553A1 Methods and compositions to treat myocardial conditions |
| 06/15/2011 | EP2331145A1 Method for determining the anti-tumor efficacy of monoclonal antibodies |
| 06/15/2011 | EP2331144A1 Fluorescent emulsion |
| 06/15/2011 | EP2331098A1 Methods for the administration of iloperidone |
| 06/15/2011 | EP2330908A1 Fluorescent cdk inhibitors for treatment of cancer |
| 06/15/2011 | CN1680432B Viral protein |
| 06/15/2011 | CN102099492A Biomarkers for depression |
| 06/15/2011 | CN102099471A Aptamer against il-17 and use thereof |
| 06/15/2011 | CN102091336A Specific magnetic resonance contrast agent for brain tumor and neurodegenerative diseases and preparation method thereof |
| 06/15/2011 | CN102091335A Gastrointestinal transit disorder diagnosis composition and use thereof |
| 06/15/2011 | CN102091027A Method for preparing antitumor small interfering RNA carrying magnetic nano probe |
| 06/14/2011 | US7960535 Recombinant lipidated PsaA protein, methods of preparation and use |
| 06/14/2011 | US7960163 Matriptase, a serine protease and its applications |
| 06/14/2011 | US7960025 Magnetic nanoparticles comprising a core formed from noble metals |
| 06/14/2011 | US7959929 isolated influenza virus that is capable of infecting a canid animal; genetic engineered influenza virus; vaccines for inducing an immune response against an influenza virus; veterinary medicine |
| 06/14/2011 | CA2475534C Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 06/14/2011 | CA2458267C Bifunctional chelating agent for actinium |
| 06/09/2011 | WO2011069082A2 Red blood cell-mimetic particles and methods for making and use thereof |
| 06/09/2011 | WO2011069019A2 J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use |
| 06/09/2011 | WO2011067576A1 Magnetic probe apparatus |
| 06/09/2011 | WO2011045454A3 Multifunctional nanostructures as spect/mri bimodal diagnosis agents |
| 06/09/2011 | US20110137228 Use of Green Porphyrins to Treat Neovasculature in the Eye |
| 06/09/2011 | US20110136221 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 06/09/2011 | US20110135799 Thickened beverages for dysphagia |
| 06/09/2011 | US20110135727 Hepatocyte Delivery Vehicle for Delivery of a Combination of Recombinant Human Regular Insulin and Recombinant Human Insulin Isophane to a Mammal |
| 06/09/2011 | US20110135707 Polyhydroxyalkanoates for in vivo applications |
| 06/09/2011 | US20110135639 B lymphocyte stimulator assays |
| 06/09/2011 | US20110135578 Mycobacterial infections |
| 06/09/2011 | US20110135577 Superparamagnetic nanoparticles IN MEDICAL THERAPEUTICS and manufacturing method THEREOF |
| 06/09/2011 | US20110135576 Dye conjugates of template-fixed peptidomimetics |
| 06/09/2011 | US20110135574 Methods of treating kidney disease |
| 06/09/2011 | US20110135573 Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| 06/09/2011 | US20110135572 Compositions and methods for diagnosing late-onset alzheimer's disease |
| 06/09/2011 | US20110135571 Hybrid nanoparticles as anti-cancer therapeutic agents and dual therapeutic/imaging contrast agents |
| 06/09/2011 | US20110135570 Anti-Tumor Cell Antigen Antibody Therapeutics |
| 06/09/2011 | US20110135568 Thickened beverages for dysphagia |
| 06/09/2011 | DE102009057274A1 Making gadobutrol, to diagnose stroke, comprises e.g. reacting N-(6-hydroxy-2,2-dimethyl-1,3-dioxepan-5-yl)-tetraaza-cyclododecane lithium chloride or bromide complex with haloacetic acid and lithium hydroxide or N-methyl imidazole |
| 06/09/2011 | CA2782387A1 Magnetic probe apparatus |
| 06/09/2011 | CA2782333A1 J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use |
| 06/09/2011 | CA2781682A1 Multispecific antibodies, antibody analogs, compositions, and methods |
| 06/08/2011 | EP2330208A1 Nanoparticles comprising RNA ligands |
| 06/08/2011 | EP2329818A1 Combination therapy with PARP inhibitors |
| 06/08/2011 | EP2329810A1 Gastric retention drug delivery system, preparation method and use thereof |
| 06/08/2011 | EP2328621A2 Fluorescent emulsion of indocyanine green |
| 06/08/2011 | EP2328620A2 Active particles for bio-analytical applications and methods for their preparation |
| 06/08/2011 | EP1919513B1 Targeted vector comprising a cyclodecapeptide RAFT and an activable imaging function |